Clinical Trial Update: Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Wujia Yizhi Granules for mild-to-moderate Alzheimer's dementia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Wujia Yizhi Granules

Snippet

Sponsor: Sichuan Jishengtang Pharmaceutical Co., Ltd. | Conditions: Alzheimer's Dementia | Phase 3 | Status: RECRUITING